Deccan Health Care
14.00
+0.79(+5.98%)
Market Cap₹34.66 Cr
PE Ratio14.36
Company Performance:
1D+5.98%
1M+0.86%
6M-27.72%
1Y-31.07%
5Y-58.33%
View Company Insightsright
More news about Deccan Health Care
04Sept 25
Deccan Health Care Reappoints Ruchi Khattar as Independent Director, Approves Annual Report
Deccan Health Care's board has reappointed Ruchi Khattar as Independent Director for a second five-year term, approved the annual report for FY 2024-25, and scheduled the 29th AGM for September 30, 2025. The board also appointed M/s. M. R. Bhatia and Co. as Secretarial Auditors for five years and made decisions regarding the e-voting process and disclosure of material events.
 no imag found
14Aug 25
Deccan Health Care Limited Approves Q1 FY2026 Financial Results
Deccan Health Care Limited's Board of Directors approved the unaudited financial results for Q1 FY2026 ending June 30, 2025. The board meeting was held on August 14, 2025, via video conferencing. Both standalone and consolidated results were approved after review by the Audit Committee. Director Mohak Gupta is authorized to sign the results. The company will upload the results on its website and submit them to BSE Limited, complying with SEBI regulations.
 no imag found
Deccan Health Care
14.00
+0.79
(+5.98%)
1 Year Returns:-31.07%
Industry Peers
Dr. Lal Path Labs
1,399.90
(-0.43%)
Vijaya Diagnostic Centre
1,004.50
(+1.95%)
Metropolis Healthcare
1,903.80
(+0.70%)
Krsnaa Diagnostics
635.45
(-0.73%)
Suraksha Diagnostic
271.45
(-0.88%)
3B BlackBio DX
1,351.50
(-7.36%)
Sastasundar Ventures
283.25
(+0.66%)